WNT-5A regulates TGF-β-related activities in liver fibrosis

American Journal of Physiology - Gastrointestinal and Liver Physiology

Volumn 312, Issue 3, 2017, Pages G219-G227

  Beljaars, Leonie ^a   Daliri, Sara ^a   Dijkhuizen, Christa ^a   Poelstra, Klaas ^a   Gosens, Reinoud ^a  

^a UNIVERSITY OF GRONINGEN   (Netherlands)

Author keywords

fibrosis; Interferon ; Remodeling; Transforming growth factor ; WNT

Indexed keywords

COLLAGEN TYPE 1; DESMIN; FIBRONECTIN; FRIZZLED PROTEIN; FRIZZLED RECEPTOR 2; FRIZZLED RECEPTOR 8; GAMMA INTERFERON; INTERLEUKIN 1BETA; PLATELET DERIVED GROWTH FACTOR BB; PROCOLLAGEN; PROCOLLAGEN 1A1; PROCOLLAGEN 3A1; RNA 18S; SCLEROPROTEIN; SMALL INTERFERING RNA; TRANSFORMING GROWTH FACTOR BETA; TUMOR NECROSIS FACTOR; UNCLASSIFIED DRUG; VIMENTIN; WNT5A PROTEIN; COLLAGEN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CARBON TETRACHLORIDE-INDUCED LIVER FIBROSIS; CELL DIFFERENTIATION; CELL STIMULATION; COLLAGEN SYNTHESIS; CONTROLLED STUDY; CYTOKINE PRODUCTION; DOWN REGULATION; FIBROGENESIS; GENE EXPRESSION REGULATION; GENE SILENCING; HEPATIC STELLATE CELL; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IN VITRO STUDY; IN VIVO STUDY; INFLAMMATION; LIVER FIBROSIS; LIVER INJURY; MALE; MOUSE; MYOFIBROBLAST; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; REGULATORY MECHANISM; SIGNAL TRANSDUCTION; UPREGULATION; ANIMAL; CELL LINE; DRUG EFFECTS; GENETICS; LIVER; LIVER CIRRHOSIS; METABOLISM; PATHOLOGY;

ANIMALS; CELL LINE; COLLAGEN; DESMIN; GENE SILENCING; HUMANS; INTERFERON-GAMMA; INTERLEUKIN-1BETA; LIVER; LIVER CIRRHOSIS; MICE; MYOFIBROBLASTS; SIGNAL TRANSDUCTION; TRANSFORMING GROWTH FACTOR BETA; WNT-5A PROTEIN;

EID: 85014593379     PISSN: 01931857     EISSN: 15221547     Source Type: Journal    
DOI: 10.1152/ajpgi.00160.2016     Document Type: Article

References (35)

1. Amrani Y, Tliba O, Choubey D, Huang CD, Krymskaya VP, Eszterhas A, Lazaar AL, Panettieri RA Jr. IFN-gamma inhibits human airway smooth muscle cell proliferation by modulating the E2F-1/Rb pathway. Am J Physiol Lung Cell Mol Physiol 284: L1063–L1071, 2003. doi: 10. 1152/ajplung.00363.2002.
2. Bansal R, Prakash J, Post E, Beljaars L, Schuppan D, Poelstra K. Novel engineered targeted interferon-gamma blocks hepatic fibrogenesis in mice. Hepatology 54: 586–596, 2011. doi: 10.1002/hep.24395.
3. Bedossa P, Peltier E, Terris B, Franco D, Poynard T. Transforming growth factor-beta 1 (TGF-beta 1) and TGF-beta 1 receptors in normal, cirrhotic, and neoplastic human livers. Hepatology 21: 760–766, 1995.10. 1002/hep.1840210325.
4. Beljaars L, Schippers M, Reker-Smit C, Martinez FO, Helming L, Poelstra K, Melgert BN. Hepatic localization of macrophage phenotypes during fibrogenesis and resolution of fibrosis in mice and humans. Front Immunol 5: 430, 2014. doi: 10.3389/fimmu.2014.00430.
5. Chatani N, Kamada Y, Kizu T, Ogura S, Furuta K, Egawa M, Hamano M, Ezaki H, Kiso S, Shimono A, Ouchi N, Yoshida Y, Takehara T. Secreted frizzled-related protein 5 (Sfrp5) decreases hepatic stellate cell activation and liver fibrosis. Liver Int 35: 2017–2026, 2015. doi: 10.1111/liv.12757.
6. Corbett L, Mann J, Mann DA. Non-canonical Wnt predominates in activated rat hepatic stellate cells, influencing HSC survival and paracrine stimulation of Kupffer cells. PLoS One 10: e0142794, 2015. doi: 10.1371/ journal.pone.0142794.
7. Dong S, Wu C, Hu J, Wang Q, Chen S, Wang Z, Xiong W. Wnt5a promotes cytokines production and cell proliferation in human hepatic stellate cells independent of canonical Wnt pathway. Clin Lab 61: 537–547, 2015.
8. Igota S, Tosa M, Murakami M, Egawa S, Shimizu H, Hyakusoku H, Ghazizadeh M. Identification and characterization of Wnt signaling pathway in keloid pathogenesis. Int J Med Sci 10: 344–354, 2013. doi: 10.7150/ijms.5349.
9. Jenei V, Sherwood V, Howlin J, Linnskog R, Säfholm A, Axelsson L, Andersson T. A t-butyloxycarbonyl-modified Wnt5a-derived hexapeptide functions as a potent antagonist of Wnt5a-dependent melanoma cell invasion. Proc Natl Acad Sci USA 106: 19473–19478, 2009. doi: 10.1073/ pnas.0909409106.
10. Jiang F, Parsons CJ, Stefanovic B. Gene expression profile of quiescent and activated rat hepatic stellate cells implicates Wnt signaling pathway in activation. J Hepatol 45: 401–409, 2006. doi: 10.1016/j.jhep.2006.03.016.
11. Kordes C, Sawitza I, Häussinger D. Canonical Wnt signaling maintains the quiescent stage of hepatic stellate cells. Biochem Biophys Res Commun 367: 116–123, 2008. doi: 10.1016/j.bbrc.2007.12.085.
12. Kumawat K, Gosens R. WNT-5A: signaling and functions in health and disease. Cell Mol Life Sci 73: 567–587, 2016. doi: 10.1007/s00018-015-2076-y.
13. Kumawat K, Menzen MH, Bos IS, Baarsma HA, Borger P, Roth M, Tamm M, Halayko AJ, Simoons M, Prins A, Postma DS, Schmidt M, Gosens R. Noncanonical WNT-5A signaling regulates TGF-+-induced extracellular matrix production by airway smooth muscle cells. FASEB J 27: 1631–1643, 2013. doi: 10.1096/fj.12-217539.
14. Kumawat K, Menzen MH, Slegtenhorst RM, Halayko AJ, Schmidt M, Gosens R. TGF-beta-activated kinase 1 (TAK1) signaling regulates TGFbeta-induced WNT-5A expression in airway smooth muscle cells via Sp1 and beta-catenin. PLoS One 9: e94801, 2014. doi: 10.1371/journal.pone.0094801.
15. Laeremans H, Hackeng TM, van Zandvoort MA, Thijssen VL, Janssen BJ, Ottenheijm HC, Smits JF, Blankesteijn WM. Blocking of frizzled signaling with a homologous peptide fragment of wnt3a/wnt5a reduces infarct expansion and prevents the development of heart failure after myocardial infarction. Circulation 124: 1626–1635, 2011. doi: 10. 1161/CIRCULATIONAHA.110.976969.
16. Li P, Cao Y, Li Y, Zhou L, Liu X, Geng M. Expression of Wnt-5a and +-catenin in primary hepatocellular carcinoma. Int J Clin Exp Pathol 7: 3190–3195, 2014.
17. Li X, Yamagata K, Nishita M, Endo M, Arfian N, Rikitake Y, Emoto N, Hirata K, Tanaka Y, Minami Y. Activation of Wnt5a-Ror2 signaling associated with epithelial-to-mesenchymal transition of tubular epithelial cells during renal fibrosis. Genes Cells 18: 608–619, 2013. doi: 10.1111/gtc.12064.
18. Lichtinghagen R, Pietsch D, Bantel H, Manns MP, Brand K, Bahr MJ. The enhanced liver fibrosis (ELF) score: normal values, influence factors and proposed cut-off values. J Hepatol 59: 236–242, 2013. doi: 10.1016/ j.jhep.2013.03.016.
19. Liu XH, Pan MH, Lu ZF, Wu B, Rao Q, Zhou ZY, Zhou XJ. Expression of Wnt-5a and its clinicopathological significance in hepatocellular carcinoma. Dig Liver Dis 40: 560–567, 2008. doi: 10.1016/j.dld. 2007.12.011.
20. Miao CG, Yang YY, He X, Huang C, Huang Y, Zhang L, Lv XW, Jin Y, Li J. Wnt signaling in liver fibrosis: progress, challenges and potential directions. Biochimie 95: 2326–2335, 2013. doi: 10.1016/j.biochi.2013.09.003.
21. Monga SP. +-Catenin signaling and roles in liver homeostasis, injury, and tumorigenesis. Gastroenterology 148: 1294–1310, 2015. doi: 10.1053/j. gastro.2015.02.056.
22. Moyes KW, Sip CG, Obenza W, Yang E, Horst C, Welikson RE, Hauschka SD, Folch A, Laflamme MA. Human embryonic stem cellderived cardiomyocytes migrate in response to gradients of fibronectin and Wnt5a. Stem Cells Dev 22: 2315–2325, 2013. doi: 10.1089/scd.2012.0586.
23. Newman DR, Sills WS, Hanrahan K, Ziegler A, Tidd KM, Cook E, Sannes PL. Expression of WNT5A in idiopathic pulmonary fibrosis and its control by TGF-+ and WNT7B in human lung fibroblasts. J Histochem Cytochem 64: 99–111, 2016. doi: 10.1369/0022155415617988.
24. Pellicoro A, Ramachandran P, Iredale JP, Fallowfield JA. Liver fibrosis and repair: immune regulation of wound healing in a solid organ. Nat Rev Immunol 14: 181–194, 2014. doi: 10.1038/nri3623.
25. Rashid ST, Humphries JD, Byron A, Dhar A, Askari JA, Selley JN, Knight D, Goldin RD, Thursz M, Humphries MJ. Proteomic analysis of extracellular matrix from the hepatic stellate cell line LX-2 identifies CYR61 and Wnt-5a as novel constituents of fibrotic liver. J Proteome Res 11: 4052–4064, 2012. doi: 10.1021/pr3000927.
26. Sato A, Kayama H, Shojima K, Matsumoto S, Koyama H, Minami Y, Nojima S, Morii E, Honda H, Takeda K, Kikuchi A. The Wnt5a-Ror2 axis promotes the signaling circuit between interleukin-12 and interferon--in colitis. Sci Rep 5: 10536, 2015. doi: 10.1038/srep10536.
27. Spanjer AI, Baarsma HA, Oostenbrink LM, Jansen SR, Kuipers CC, Lindner M, Postma DS, Meurs H, Heijink IH, Gosens R, Königshoff M. TGF-+-induced profibrotic signaling is regulated in part by the WNT receptor Frizzled-8. FASEB J 30: 1823–1835, 2016. doi: 10.1096/fj. 201500129.
28. Trautwein C, Friedman SL, Schuppan D, Pinzani M. Hepatic fibrosis: concept to treatment. J Hepatol 62, Suppl: S15–S24, 2015. doi: 10.1016/ j.jhep.2015.02.039.
29. Uitterdijk A, Hermans KC, de Wijs-Meijler DP, Daskalopoulos EP, Reiss IK, Duncker DJ, Matthijs Blankesteijn W, Merkus D. UM206, a selective Frizzled antagonist, attenuates adverse remodeling after myocardial infarction in swine. Lab Invest 96: 168–176, 2016. doi: 10.1038/ labinvest.2015.139.
30. Ulloa L, Doody J, Massagué J. Inhibition of transforming growth factor-beta/SMAD signalling by the interferon-gamma/STAT pathway. Nature 397: 710–713, 1999. doi: 10.1038/17826.
31. Valencia J, Martinez VG, Hidalgo L, Hernandez-Lopez C, Canseco NM, Vicente A, Varas A, Sacedon R. Wnt5a signaling increases IL-12 secretion by human dendritic cells and enhances IFN-gamma production by CD4T cells. Immunol Lett 162: 188–199, 2014. doi: 10.1016/j.imlet.2014.08.015.
32. van Dijk F, Olinga P, Poelstra K, Beljaars L. Targeted therapies in liver fibrosis: combining the best parts of platelet-derived growth factor BB and interferon gamma. Front Med (Lausanne) 2: 72, 2015. doi: 10.3389/fmed. 2015.00072.
33. Vuga LJ, Ben-Yehudah A, Kovkarova-Naumovski E, Oriss T, Gibson KF, Feghali-Bostwick C, Kaminski N. WNT5A is a regulator of fibroblast proliferation and resistance to apoptosis. Am J Respir Cell Mol Biol 41: 583–589, 2009. doi: 10.1165/rcmb.2008-0201OC.
34. Xiong WJ, Hu LJ, Jian YC, Wang LJ, Jiang M, Li W, He Y. Wnt5a participates in hepatic stellate cell activation observed by gene expression profile and functional assays. World J Gastroenterol 18: 1745–1752, 2012. doi: 10.3748/wjg.v18.i15.1745.
35. Xu L, Hui AY, Albanis E, Arthur MJ, O’Byrne SM, Blaner WS, Mukherjee P, Friedman SL, Eng FJ. Human hepatic stellate cell lines, LX-1 and LX-2: new tools for analysis of hepatic fibrosis. Gut 54: 142–151, 2005. doi: 10.1136/gut.2004.042127.